Why More Than Half of U.S. Adults Now Qualify for Ozempic and Wegovy
Key Insights on Ozempic and Wegovy
A recent study from JAMA Cardiology reveals that over 140 million Americans might be candidates for weight loss drugs Ozempic and Wegovy. Dr. Natalie Azar, a medical contributor for NBC, discusses these findings in a segment aired on November 19, 2024.
Video Overview
Title: More than half of US adults are now eligible for Ozempic, Wegovy
Duration: 02:10
Summary: This video explores the growing eligibility of adults for these weight loss medications and examines the implications for health and wellness.
Related Videos
-
Fact vs. myth: What to know about potatoes, dairy-free milk, more
Duration: 05:07
Link: Watch Here -
Food safety concerns grow following string of illness outbreaks
Duration: 02:41
Link: Watch Here -
Improve balance and build strength with this at-home workout
Duration: 03:39
Link: Watch Here -
E. coli outbreak linked to organic carrots sold in large retailers
Duration: 00:37
Link: Watch Here - How to keep to healthy routines throughout the holiday season
Duration: 04:08
Link: Watch Here
Dr. Azar’s insights highlight the potential benefits of these medications for weight management in a significant portion of the adult population in the U.S. This coverage allows viewers to understand both the medical background and the personal implications of such treatments.